Micro Cap Growth Fund
Daily price w/o sales charge as of 05/02/2025
$18.19
$0.40
YTD Returns w/o sales charge as of 05/02/2025
-12.80%
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 03/31/2025
- Total Net Assets
- $160.90 M
- Inception Date
- 08/28/2020
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 2.13%
- Fund Net Expense Ratio
- 2.13%
- Number of Holdings
- 73
- Minimum Initial Investment
- $1,500+
Fund Expense Ratio :
Gross 2.13%
Net 2.13%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 08/01/2010 |
---|
YTD |
1-YR |
3-YR |
5-YR |
10-YR |
Since Inception 08/01/2010 |
|
---|---|---|---|---|---|---|
w/o sales charge | -15.72% | 6.10% | 3.17% | 9.80% | 9.30% | 9.42% |
Lipper Category Avg. Small-Cap Growth Funds | - | - | - | - | - | - |
Russell Microcap® Growth Index | -15.64% | 4.95% | 2.04% | 5.01% | 3.26% | - |
w/ sales charge | -16.57% | 5.10% | 3.17% | 9.80% | 9.30% | 9.42% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
Gross 2.13%
Net 2.13%
Fund Expense Ratio :
Gross 2.13%
Net 2.13%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 08/01/2010 |
---|
YTD |
1-YR |
3-YR |
5-YR |
10-YR |
Since Inception 08/01/2010 |
|
---|---|---|---|---|---|---|
w/o sales charge | -18.07% | -3.93% | -2.68% | 13.00% | 8.51% | 9.33% |
Lipper Category Avg. Small-Cap Growth Funds | -10.55% | -5.61% | -0.42% | 11.22% | 7.24% | - |
Russell Microcap® Growth Index | -17.75% | -5.93% | -3.79% | 8.16% | 2.70% | - |
w/ sales charge | -18.89% | -4.90% | -2.68% | 13.00% | 8.51% | 9.33% |
Fund Expense Ratio :
Gross 2.13%
Net 2.13%
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
TEN LARGEST HOLDINGS as of 03/31/2025View Portfolio
Holding |
Assets |
---|---|
Tarsus Pharmaceuticals Inc | 4.0% |
Universal Technical Institute Inc | 3.3% |
Natural Grocers by Vitamin Cottage Inc | 2.8% |
Chefs' Warehouse Inc/The | 2.7% |
Grindr Inc | 2.6% |
CRA International Inc | 2.5% |
OSI Systems Inc | 2.5% |
Mirum Pharmaceuticals Inc | 2.4% |
Grid Dynamics Holdings Inc | 2.4% |
Scholar Rock Holding Corp | 2.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 03/31/2025View Portfolio
Sector | Weighting |
---|
Sector | Weighting |
---|---|
Communication Services | |
Real Estate | |
Utilities | |
Consumer Discretionary | |
Consumer Staples | |
Energy | |
Financials | |
Health Care | |
Industrials | |
Information Technology | |
Materials |
INVESTMENT TEAM



Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 2.13%
Net 2.13%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 08/01/2010 |
---|
YTD |
1-YR |
3-YR |
5-YR |
10-YR |
Since Inception 08/01/2010 |
|
---|---|---|---|---|---|---|
w/o sales charge | -15.72% | 6.10% | 3.17% | 9.80% | 9.30% | 9.42% |
Lipper Category Avg. Small-Cap Growth Funds | - | - | - | - | - | - |
Russell Microcap® Growth Index | -15.64% | 4.95% | 2.04% | 5.01% | 3.26% | - |
w/ sales charge | -16.57% | 5.10% | 3.17% | 9.80% | 9.30% | 9.42% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
Gross 2.13%
Net 2.13%
Fund Expense Ratio :
Gross 2.13%
Net 2.13%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 08/01/2010 |
---|
YTD |
1-YR |
3-YR |
5-YR |
10-YR |
Since Inception 08/01/2010 |
|
---|---|---|---|---|---|---|
w/o sales charge | -18.07% | -3.93% | -2.68% | 13.00% | 8.51% | 9.33% |
Lipper Category Avg. Small-Cap Growth Funds | -10.55% | -5.61% | -0.42% | 11.22% | 7.24% | - |
Russell Microcap® Growth Index | -17.75% | -5.93% | -3.79% | 8.16% | 2.70% | - |
w/ sales charge | -18.89% | -4.90% | -2.68% | 13.00% | 8.51% | 9.33% |
Fund Expense Ratio :
Gross 2.13%
Net 2.13%
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
Year | Fund Returns | Russell Microcap® Growth Index |
---|
Year |
Fund Returns |
Russell Microcap® Growth Index |
---|---|---|
2024 | 26.04% | 21.91% |
2023 | 5.01% | 9.11% |
2022 | -29.80% | -29.76% |
2021 | 2.75% | 0.88% |
2020 | 77.90% | 40.13% |
2019 | 33.23% | 23.33% |
2018 | 1.83% | -14.18% |
2017 | 37.02% | 16.65% |
2016 | 1.04% | 6.86% |
2015 | -7.32% | -3.85% |
2014 | 9.74% | - |
2013 | 76.86% | - |
2012 | 1.59% | - |
2011 | -6.61% | - |
Year | Q1 | Q2 | Q3 | Q4 |
---|
Year |
Q1 |
Q2 |
Q3 |
Q4 |
---|---|---|---|---|
2025 | -18.07% | - | - | - |
2024 | 7.49% | -0.06% | 6.64% | 10.02% |
2023 | 5.33% | 3.98% | -13.62% | 11.00% |
2022 | -17.42% | -22.71% | 8.03% | 1.81% |
2021 | 12.08% | -0.29% | -9.62% | 1.72% |
2020 | -24.47% | 47.31% | 17.25% | 36.36% |
2019 | 22.33% | 7.20% | -14.11% | 18.30% |
2018 | 5.07% | 15.49% | 9.76% | -23.55% |
2017 | 8.70% | 7.90% | 13.35% | 3.06% |
2016 | -13.88% | 5.67% | 14.28% | -2.86% |
2015 | 7.07% | 3.87% | -16.51% | -0.19% |
2014 | 7.62% | -6.73% | -6.83% | 17.34% |
2013 | 21.51% | 14.77% | 17.00% | 8.39% |
2012 | 17.46% | -9.89% | 1.07% | -5.03% |
2011 | 4.58% | -0.03% | -22.09% | 14.64% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
NAV Historical Prices
Date | Net Asset Value |
---|
Portfolio
Portfolio
Holding | Sector | Assets |
---|
Holding |
Sector |
Assets |
---|---|---|
Tarsus Pharmaceuticals Inc | Health Care | 4.0% |
Universal Technical Institute Inc | Consumer Discretionary | 3.3% |
Natural Grocers by Vitamin Cottage Inc | Consumer Staples | 2.8% |
Chefs' Warehouse Inc/The | Consumer Staples | 2.7% |
Grindr Inc | Communication Services | 2.6% |
CRA International Inc | Industrials | 2.5% |
OSI Systems Inc | Information Technology | 2.5% |
Mirum Pharmaceuticals Inc | Health Care | 2.4% |
Grid Dynamics Holdings Inc | Information Technology | 2.4% |
Scholar Rock Holding Corp | Health Care | 2.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Holding | Sector | Assets |
---|
Holding |
Sector |
Assets |
---|---|---|
Tarsus Pharmaceuticals Inc | Health Care | 4.0% |
Universal Technical Institute Inc | Consumer Discretionary | 3.3% |
Natural Grocers by Vitamin Cottage Inc | Consumer Staples | 2.8% |
Chefs' Warehouse Inc/The | Consumer Staples | 2.7% |
Grindr Inc | Communication Services | 2.6% |
CRA International Inc | Industrials | 2.5% |
OSI Systems Inc | Information Technology | 2.5% |
Mirum Pharmaceuticals Inc | Health Care | 2.4% |
Grid Dynamics Holdings Inc | Information Technology | 2.4% |
Scholar Rock Holding Corp | Health Care | 2.2% |
Paymentus Holdings Inc | Financials | 2.2% |
Argan Inc | Industrials | 2.1% |
Stride Inc | Consumer Discretionary | 1.9% |
Vita Coco Co Inc/The | Consumer Staples | 1.9% |
Alkami Technology Inc | Information Technology | 1.8% |
Weave Communications Inc | Information Technology | 1.8% |
PAR Technology Corp | Information Technology | 1.8% |
Kratos Defense & Security Solutions Inc | Industrials | 1.8% |
Cellebrite DI Ltd | Information Technology | 1.7% |
Life360 Inc | Information Technology | 1.7% |
IMAX Corp | Communication Services | 1.7% |
GeneDx Holdings Corp | Health Care | 1.7% |
Arcellx Inc | Health Care | 1.5% |
VSE Corp | Industrials | 1.4% |
Travere Therapeutics Inc | Health Care | 1.4% |
Powerfleet Inc NJ | Information Technology | 1.4% |
Willdan Group Inc | Industrials | 1.4% |
Artivion Inc | Health Care | 1.4% |
Powell Industries Inc | Industrials | 1.4% |
Payoneer Global Inc | Financials | 1.4% |
Limbach Holdings Inc | Industrials | 1.4% |
PROCEPT BioRobotics Corp | Health Care | 1.4% |
Vital Farms Inc | Consumer Staples | 1.3% |
QuinStreet Inc | Communication Services | 1.3% |
Primoris Services Corp | Industrials | 1.3% |
CareDx Inc | Health Care | 1.3% |
Ambarella Inc | Information Technology | 1.2% |
Piper Sandler Cos | Financials | 1.2% |
Oddity Tech Ltd | Consumer Staples | 1.2% |
Phreesia Inc | Health Care | 1.2% |
Opera Ltd | Information Technology | 1.2% |
Centessa Pharmaceuticals PLC | Health Care | 1.1% |
Adaptive Biotechnologies Corp | Health Care | 1.1% |
Marex Group PLC | Financials | 1.1% |
Xometry Inc | Industrials | 1.0% |
Veracyte Inc | Health Care | 1.0% |
Sterling Infrastructure Inc | Industrials | 1.0% |
Rhythm Pharmaceuticals Inc | Health Care | 1.0% |
OneSpaWorld Holdings Ltd | Consumer Discretionary | 1.0% |
Sweetgreen Inc | Consumer Discretionary | 0.9% |
Warby Parker Inc | Consumer Discretionary | 0.9% |
Evolus Inc | Health Care | 0.9% |
Ceribell Inc | Health Care | 0.8% |
NeuroPace Inc | Health Care | 0.8% |
Core Scientific Inc | Information Technology | 0.8% |
UFP Technologies Inc | Health Care | 0.8% |
89bio Inc | Health Care | 0.8% |
uniQure NV | Health Care | 0.7% |
Vericel Corp | Health Care | 0.7% |
Credo Technology Group Holding Ltd | Information Technology | 0.7% |
CVRx Inc | Health Care | 0.7% |
Janux Therapeutics Inc | Health Care | 0.7% |
Soleno Therapeutics Inc | Health Care | 0.6% |
Enliven Therapeutics Inc | Health Care | 0.5% |
Agilysys Inc | Information Technology | 0.5% |
Viant Technology Inc | Information Technology | 0.5% |
Twist Bioscience Corp | Health Care | 0.5% |
Xenon Pharmaceuticals Inc | Health Care | 0.5% |
Vera Therapeutics Inc | Health Care | 0.5% |
Butterfly Network Inc | Health Care | 0.5% |
Beta Bionics Inc | Health Care | 0.4% |
Intuitive Machines Inc | Industrials | 0.3% |
LENZ Therapeutics Inc | Health Care | 0.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 03/31/2025
Sector | Weighting | Fund Change from Previous Quarter |
---|
Sector | Weighting | Fund Change from Previous Quarter |
---|---|---|
Communication Services |
![]() |
|
Real Estate | 0.0% | |
Utilities | 0.0% | |
Consumer Discretionary |
![]() |
|
Consumer Staples |
![]() |
|
Energy | 0.0% | |
Financials |
![]() |
|
Health Care | 0.0% | |
Industrials |
![]() |
|
Information Technology |
![]() |
|
Materials | 0.0% |
Portfolio Details as of 03/31/2025
- Total Net Assets
- $160.90 M
- Number of Holdings
- 73
- Weighted Average Market Cap.
- 2.2 B
- P/B Ratio
- 4.9x
- P/E Ratio
- 28.6x
To view definitions for the above Portfolio Details, Click here.
Dividends & Cap Gains
Dividends & Cap Gains
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
Record Date | Ex-Dividend Date | Reinvest & Payable Date |
---|---|---|
12/01/2025 | 12/02/2025 | 12/02/2025 |
Capital Gains Distributions
Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
---|---|---|---|---|---|
11/23/2020 | 11/24/2020 | $2.8043 | $2.2741 | $5.0784 | $18.85 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Expense Ratioas of 03/31/2025
Fund Gross Expense Ratio | 2.13% |
Fund Net Expense Ratio | 2.13% |
Fund Documents
Fund Documents
0Documents selected
|
||||
---|---|---|---|---|
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
Summary Prospectus
Publish Date:11/03/2015
|
||||
Statutory Prospectus
Publish Date:11/03/2015
|
||||
SAI
Publish Date:11/03/2015
|
||||
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
Fact Sheet
Publish Date:11/03/2015
|